PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 5, 2026Journal of Geriatric Cardiology0 citationsOpen Access

CT-derived fractional flow reserve combined with atherosclerotic extent to determine long-term outcomes in diabetic patients with coronary artery disease

ZWZhi-Qiang WANGZLZhennan LiZHZhi-Hui HOU

Key Points

  • The research aims to assess the prognostic value of CT-derived fractional flow reserve and atherosclerotic extent in diabetic patients with coronary artery disease over the long term.
  • Conducted a retrospective pooled analysis of individual patient data
  • Calculated deep-learning-based vessel-specific CT-derived fractional flow reserve
  • Followed up patients for at least 5 years to monitor outcomes
  • 55 patients (11.5%) experienced major adverse cardiac events during the follow-up period
  • CT-derived fractional flow reserve ≤ 0.80 was an independent predictor of adverse outcomes (HR: 6.54)
  • Adding CT-FFR to the atherosclerotic extent model improved predictive ability (C-index increased from 0.75 to 0.81)

Abstract

Background There is still limited data on predictive value of coronary computed tomography angiography (CCTA)–derived fractional flow reserve (CT-FFR) for long term outcomes. We examined the long-term prognostic value of CT-FFR combined with CCTA–defined atherosclerotic extent in diabetic patients with coronary artery disease (CAD). Methods A retrospective pooled analysis of individual patient data was performed. Deep-learning-based vessel-specific CT-FFR was calculated. All patients enrolled were followed-up for at least 5 years. Predictive abilities for major adverse cardiac events (MACE) were compared among three models (model 1, constructed using clinical variables; model 2, model 1+CCTA–derived atherosclerotic extent (Leiden risk score); and model 3, model 2+CT-FFR. Results A total of 480 diabetic patients median age, 61 (55–66) years; 52.9% men were included. During a median follow-up time of 2197 (2126–2355) days, 55 patients (11.5%) experienced MACE. In multivariate-adjusted Cox models, Leiden risk score (HR: 1.06; 95% CI: 1.01–1.11; P = 0.013) and CT-FFR ≤ 0.80 (HR: 6.54; 95% CI: 3.18–13.45; P vs. 0.63; P vs. 0.75; P = 0.002). Net reclassification improvement (NRI) was 0.19 (P = 0.009) for model 2 beyond model 1. Of note, adding CT-FFR to model 3 also exhibited significantly improved reclassification compared with model 2 (NRI = 0.14; P = 0.011). Conclusion In diabetic patients with CAD, CT-FFR provides robust and incremental prognostic information for predicting long-term outcomes. The combined model exhibits improved prediction abilities, which is beneficial for risk stratification.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

WANG et al. (2026) studied this question.

synapsesocial.com/papers/69a91d9bd6127c7a504c096dhttps://doi.org/10.26599/1671-5411.2026.01.008
Ask AI
Helpful
Bookmark
Share
View Full Paper